By Steve Scherer ( September 24, 2026, 14:52 GMT | Insight) -- Licensing activity ranged across pharmaceuticals, cloud infrastructure, cybersecurity, connected vehicles, medical AI and data-center power, as companies struck drug-development and commercialization deals, traded patent portfolios, expanded licensing pools and secured rights to foundational computing technologies.Novartis, Bayer, Ericsson, Ford and General Motors were among the major companies involved in the latest round of licensing activity and IP transactions, which spanned pharmaceuticals, connected vehicles, cloud networks, cybersecurity and artificial intelligence. The deals included a radioligand therapy agreement worth up to $900 million, a planned 375 million-euro sale of an established cancer drug, transfers of networking and security patents, new Wi-Fi 6 pool licensees and agreements covering medical-data models and power-delivery technology for AI processors....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.